Bryant Furlow

Recent and upcoming case reports suggest possible cases of gluteal and other implant-associated ALCLs, raising questions about the cancer risk across all types of implants.

Hypofractionated radiotherapy (HRT) offers quality-of-life outcomes similar to conventional radiation therapy for men with low-risk prostate cancer, according to recently published results of a phase 3 randomized study. HRT offers a less expensive and more convenient treatment option for some patients, and in light of the new findings about quality of life, should be considered…

An overview of safe handling concerns regarding handling and administration of a recently approved receptor-binding radionuclide.

A report from a European working group of pediatric radiation oncologists focuses on recommendations for safer delivery of radiotherapy to children, especially in dose distributions involving spinal vertebrae.

Most patients undergoing anticancer chemotherapy or radiation therapy will experience treatment-induced nausea and vomiting. But key gaps remain in our understanding of how best to prevent and treat this debilitating adverse effect, leading to inconsistencies among clinical antiemetic guidelines. The available evidence for how best to prevent and manage nausea and vomiting during and following…

Percutaneous microwave ablation (MWA) is a promising treatment strategy for patients with cT1-stage renal tumors, but more research into patient risk stratification and selection is needed.

New joint guideline from ASTRO, ASCO, and AUA offers an alternative to conventional radiation regimens for those patients who opt for treatment instead of active surveillance or surgery.

Overall, patient survival was not associated with surgical technique.

Transplanting fecal bacteria from healthy donors might prove to be effective in resolving cancer immunotherapy-triggered colitis, a pair of case reports has suggested.